Table 3. The responses in the two groups (NSE < 26.1/NSE ≥ 26.1 ng/ml).
Variable | Number of all patients (%) | |
---|---|---|
NSE < 26.1 ng/ml | NSE ≥ 26.1 ng/ml | |
Overall | 298 (100) | 65 (100) |
CR | 0 (0.0) | 0 (0.0) |
PR | 56 (18.79) | 2 (3.08) |
SD | 81 (27.18) | 12 (18.46) |
Progressive disease | 161 (54.03) | 51 (78.46) |
ORR | 56 (18.79) | 2 (3.08) |
DCR | 137 (45.97) | 14 (21.54) |